& Kimmelman, A
The approved starting dose is 2.5 mg, with escalation by 2.5 mg every four weeks to a maximum of 15 mg [4]
Pentadeca Arginate has demonstrated potential in reversing opioid tolerance, allowing patients to achieve effective pain relief with lower doses of opioids
Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
The specific documents required are noted on each form, and missing supporting materials can delay the review process